Core Viewpoint - Goldstorm Metals Corp. is increasing its previously announced private placement financing to approximately $2.1 million due to strong investor demand [2]. Group 1: Offering Details - The Offering will consist of up to 15,441,483 non-flow-through units (NFT Units) priced at $0.07 each, generating gross proceeds of approximately $1,080,903.81 [2]. - Additionally, the Offering will include up to 10,071,428 flow-through units (Charity FT Units) priced at $0.1008 each, expected to raise about $1,015,199.94 [2]. - Each NFT Unit includes one common share and one-half of a warrant, while each Charity FT Unit consists of one common share and one-half of a warrant [3]. Group 2: Use of Proceeds - Net proceeds from the NFT Units will be allocated for working capital and general corporate purposes [4]. - Gross proceeds from the Charity FT Units will be used for Canadian exploration expenses, qualifying as flow-through mining expenditures [5]. Group 3: Offering Timeline and Conditions - The closing of the Offering is anticipated around June 26, 2025 [6]. - All securities issued will be subject to a statutory four-month hold period and require regulatory approval, including from the TSXV [7]. Group 4: Company Overview - Goldstorm Metals Corp. is focused on precious and base metals exploration, holding a significant land position in British Columbia's Golden Triangle, known for high-grade gold deposits [9]. - The company's flagship projects, Crown and Electrum, cover approximately 16,469 hectares across six concessions, with strategic proximity to major gold deposits [9].

Core Viewpoint - Quantum Critical Metals Corp. plans to raise between $2,000,000 to $3,000,000 through a non-brokered private placement financing by selling 20,000,000 to 30,000,000 units at a price of $0.10 per unit, with each unit consisting of one common share and one warrant [1][2]. Group 1 - The net proceeds from the Offering will be used for continued exploration activities on the Company's properties in British Columbia and Quebec, as well as for general corporate purposes [2]. - The Offering is expected to close on or about June 30, 2025, and may be completed in one or more tranches, subject to TSX Venture Exchange approval and customary conditions for private placements [3]. - All securities issued will be subject to a statutory hold period of four months and one day from the date of issue [3]. Group 2 - The Company may pay a finder's fee to certain individuals who introduce purchasers to the Offering, in accordance with TSXV policies [4]. - Certain insiders are expected to participate in the Offering, which qualifies as a "related party transaction" under Multilateral Instrument 61-101, but is exempt from formal valuation and minority shareholder approval requirements [5]. Group 3 - Quantum Critical Metals Corp. is a Canadian mineral exploration company focused on advancing critical metals projects, with a portfolio that includes various projects in Quebec and British Columbia [8].

Corporate Update - Search Minerals Inc. has announced a corporate update including the reinstatement of trading on the TSX Venture Exchange (TSXV) expected around June 17, 2025 [4] - The company faced a cease trade order (CTO) due to failure to file annual audited financial statements for the year ended November 30, 2023 [2][3] - A new Board of Directors was elected on June 21, 2024, to address management issues and has since worked to remedy the company's situation [3] Financial Position - The company's interim financial statements for the three months ended February 28, 2025, show a working capital deficiency of $5,282,051 [6] - The deficiency is primarily due to accounts payable and accrued liabilities totaling $2,885,836 and other debts [7] - The company plans to seek financing through a private placement to return to a positive working capital position [11] Financing and Debt - Search Minerals intends to conduct a non-brokered private placement to raise approximately $12 million, with each unit consisting of one share and one warrant [11] - The company has entered into a loan agreement for an unsecured loan of $750,000 to support its operations [16][17] - The loan bears an interest rate of 15% per annum and is payable by August 30, 2026, or upon closing of any financing exceeding $2.5 million [17] Share Consolidation - The company plans to consolidate its shares on a basis of ten pre-consolidation shares for one post-consolidation share, reducing the number of outstanding shares from approximately 417.99 million to about 41.80 million [18][19] - The consolidation is expected to take effect on or about June 17, 2025 [18] Annual General Meeting - The company intends to hold its annual general meeting on July 24, 2025, to comply with TSXV Policy 3.1 [25] - The last annual meeting was held on May 25, 2022, and the company has not been in compliance since then [23][24] Management Changes - The new Board appointed Joseph Lanzon as CEO and Greg Andrews as CFO and Corporate Secretary, although Andrews resigned later [27] - The company is currently not in compliance with TSXV Policy 3.1 regarding management structure and audit committee requirements [26][27]

Group 1 - Collective Metals Inc. intends to complete a non-brokered private placement financing of up to 4,180,000 units at a price of $0.06 per unit, aiming for aggregate gross proceeds of up to $250,800 [1][2] - Each unit will consist of one common share and one share purchase warrant, with the warrant allowing the purchase of one share at an exercise price of $0.075 for a period of 24 months [1][2] - The net proceeds from the offering are intended for general corporate and working capital purposes [2] Group 2 - The closing of the offering is subject to certain conditions, including the receipt of necessary regulatory approvals [2] - The company may pay finder's fees in connection with the offering, and there will be a hold period of four months and one day on all securities issued under the placement [2] - Collective Metals Inc. specializes in precious metals exploration in North America, with its flagship property being the Princeton Project located in British Columbia [4] Group 3 - The Landings Lake Lithium Project, located in northwestern Ontario, hosts significant reserves of lithium [5] - The Landings Lake Project covers 3,146 hectares and is situated 53 km east of Ear Falls, Ontario [5] - The Whitemud Project, neighboring the Landings Lake Project, consists of 381 single cell mining claims totaling 7,775 hectares [5]

Core Viewpoint - Western Uranium & Vanadium Corp. plans to raise approximately CAD $5 million through a bought deal private placement financing, with the offering expected to close around June 13, 2025 [1][2]. Group 1: Offering Details - The offering consists of 5,882,374 units priced at CAD $0.85 each, with each unit comprising one common share and one common share purchase warrant, exercisable at CAD $1.05 for four years [1]. - A.G.P. Canada Investments ULC will act as the sole underwriter and bookrunner, with A.G.P./Alliance Global Partners serving as the sole U.S. placement agent [1]. - The offering will be conducted under the accredited investor exemption in Canada and will also be available to U.S. purchasers under certain exemptions from registration requirements [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated for expanding production capabilities at the Sunday Mine Complex, developing minerals processing facilities, and acquiring uranium/vanadium properties near existing production centers [3]. Group 3: Related Party Transaction - CEO George Glasier intends to subscribe for 117,647 units, which is classified as a related-party transaction under Multilateral Instrument 61-101 [2]. - The company will rely on exemptions from formal valuation and minority shareholder approval requirements, as Glasier's participation will not exceed 25% of the company's market capitalization [2]. Group 4: Company Overview - Western Uranium & Vanadium Corp. is focused on ramping up high-grade uranium and vanadium production at its Sunday Mine Complex, with additional projects in Colorado and Utah [8]. - The Mustang Mineral Processing Site is being developed to optimize the recovery of mined materials [8].

Core Viewpoint - Onyx Gold Corp. has successfully closed the second and final tranche of its non-brokered private placement, raising a total of approximately $13.04 million since May 2025, which will be used to advance exploration initiatives in Ontario and Yukon [1][3]. Group 1: Private Placement Details - The second tranche involved the issuance of 1,709,657 common shares at a price of $1.19 per share, resulting in gross proceeds of approximately $2.03 million [1]. - An existing strategic investor will own approximately 9.4% of the issued and outstanding common shares following the closing of the private placement [2]. - The private placement is subject to final acceptance by the TSX Venture Exchange and the shares will be subject to a hold period of four months and one day [4]. Group 2: Use of Proceeds - The company plans to use the gross proceeds from the sale of flow-through shares to incur "Qualifying Expenditures" related to its projects in Ontario and Yukon, with a deadline for incurring these expenditures set for December 31, 2026 [3]. - The company will renounce all Qualifying Expenditures in favor of the subscribers of the flow-through shares effective December 31, 2025 [3]. Group 3: Company Overview - Onyx Gold is focused on exploration in established Canadian mining jurisdictions, with assets in Timmins, Ontario, and Yukon Territory [6]. - The company has a portfolio that includes the Munro-Croesus Gold property, known for high-grade mineralization, and additional exploration properties [6][8]. - Onyx Gold controls four properties in the Selwyn Basin area of Yukon Territory, which is gaining significance due to recent discoveries [8].

Core Points - Goldstorm Metals Corp. announced a non-brokered private placement offering of units at a price of $0.07 per unit for total gross proceeds of up to $1,000,000 [1][2] Group 1: Offering Details - Each unit consists of one common share and one-half of a common share purchase warrant, with each whole warrant allowing the purchase of one common share at an exercise price of $0.10 for 24 months [2] - The company may pay finders a fee in cash, finder's warrants, or both, based on the proceeds raised from the offering [3] - All securities issued will be subject to a four-month hold period and the offering is subject to regulatory approval [4] Group 2: Company Overview - Goldstorm Metals Corp. is focused on precious and base metals exploration, holding a significant land position in the Golden Triangle of British Columbia, known for high-grade gold deposits [5] - The company's flagship projects, Crown and Electrum, cover approximately 16,469 hectares across six concessions, with strategic locations near major gold deposits [5]

Core Points - ORIC Pharmaceuticals, Inc. has announced a private placement of approximately 19.2 million shares at a price of $6.50 per share, representing an 18% premium to its 10-day trailing volume-weighted average price as of May 23, 2025 [1][2] - The financing is expected to generate gross proceeds of approximately $125 million, which will fund the company's operating plan into the second half of 2027 and support the primary endpoint readout from the first ORIC-944 Phase 3 trial in prostate cancer [1][3] Financing Details - The financing is led by SR One and includes participation from various institutional investors such as Point72, Viking Global Investors, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), Nextech, Vivo Capital, and NEXTBio Capital [1][2] - The pre-funded warrants will have an exercise price of $0.0001 per share and will be immediately exercisable [1] Use of Proceeds - ORIC intends to utilize the net proceeds from the financing for research and development of its clinical-stage product candidates, working capital, and general corporate purposes [3] - The combined proceeds from this financing and existing cash, cash equivalents, and marketable securities are expected to be sufficient to fund the current operating plan through the anticipated primary endpoint readout from the ORIC-944 Phase 3 trial [3] Company Overview - ORIC Pharmaceuticals is focused on developing treatments that address mechanisms of therapeutic resistance in cancer, with key product candidates including ORIC-944 for prostate cancer and ORIC-114 for multiple genetically defined cancers [6] - The company operates from offices in South San Francisco and San Diego, California [6]

“NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.” VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that, due to strong investor demand, it has agreed with Clarus Securities Inc. (the “Lead Agent”), as Lead Agent and sole bookrunner, on behalf of a syndicate of agents (the “Agents”), to increase the size of its previously announced $5,000 ...